The Role of Real-World Evidence in the Price and Reimbursement Decisions for Rare Diseases... 02/04/2024 Healthcare Rare diseases Innovative drugs Financing Real-world evidence (RWE) is a promising source of data that could help to accelerate drug access in rare diseases. Partners
The city of Vigo will host the next edition of "Galicia Biodays" on June 12 and 13 01/04/2024 Healthcare International Financing Talento On June 12 and 13, Vigo will become the capital of biotechnology for the celebration of the II edition of "Galicia... Partners - BIOGA
AseBio welcomes the measures proposed by the European Commission to promote biotechnology ... 25/03/2024 Industrial biotechnology Financing Talento We consider it a priority to accelerate its implementation and broaden its scope of action to enhance and promote the... AseBio
Engrail Therapeutics Closes Oversubscribed $157M Series B Financing Round to Advance the ... 20/03/2024 Healthcare Personalized medicine Financing Ysios Capital participates in the financing round for the capital increase of the US company Engrail Therapeutics. Partners - Ysios Capital Partners
Mahana Therapeutics acquires Cara Care (Asabys) to become a global platform for digital th... 12/03/2024 Healthcare Financing Corporate The combination creates a global company that offers the most comprehensive digestive health portfolio available today. Partners - Asabys Partners
AbilityPharma closes €7 million round for metastatic pancreatic cancer drug ABTL0812 11/03/2024 Healthcare Rare diseases Advanced therapies Financing AbilityPharma closes €7 million round to fully fund its international Phase 2b clinical trial with the antitumor drug... Partners - Ability Pharmaceuticals
AseBio Investor Day 2024 focuses on the increasing interest of investors in the bioeconomy... 11/03/2024 Bioeconomy Financing The benchmark event for investors and biotechnology companies will host a panel discussion focused on the challenge of... AseBio
Spanish researchers to design proteins using AI to make advanced therapies more efficient 04/03/2024 Healthcare Rare diseases Financing The project will be undertaken by a public-private consortium formed by VIVEbiotech, Integra Therapeutics and OneChain... Partners - VIVEbiotech
ProductLife Group as a strategic partner of an EIT Health consortium supporting an innovat... 28/02/2024 EU projects Financing ProductLife Group, partner of the ET Health consortium, APNEAL project, as a regulatory figure and to accelerate patient... Partners - ProductLife Group
Algenex receives a $3.12 million grant through CEPI to support its research 14/02/2024 Healthcare Access to innovation Innovative drugs Financing Algenex states that current production methods for recombinant proteins present “a series of challenges in respect to... Partners - Algenex
